Abstract
Chemotherapeutic regimen with busulfan (Bu) has been extensively applied to the treatment of neoplastic and non-neoplastic hematological disturbances, leading to satisfactory results regarding to success of hematopoietic stem cells transplantation (HSCT). Individual monitoring of Bu dosage is required for determination of the ideal therapeutic levels and for minimizing the systemic toxici…